Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
Alfred Zippelius, Sara M. Tolaney, Paolo Tarantino, Joseph P. Balthasar, Greg M. Thurber
Topics & Concepts
Immune systemCancer treatmentComputational biologyImmunotherapyDrugCancer researchCancerDrug developmentMedicineRational designCytotoxic T cellBiologyClinical trialCancer therapyImmunologyCytotoxicityClinical efficacyConjugateCancer immunotherapyChimeric antigen receptorAntigenCellBioinformaticsClinical PracticeAntibody-drug conjugateCancer cellAcquired immune systemPrecision medicineCell cultureDendritic cellDrug discoveryHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research